PhillipsonJD. Natural products as drugs. Trans R Soc Trop Med Hyg1994; 88(Suppl 1): 17–19.
2.
PrincipePP. The economic significance of plants and their constituent drugs. In: WagnerHHikinoHFarnsworthNR, eds. Economic and Medicinal Plant Research, Vol. 3. London: Academic Press, 1989:1–17.
3.
PetersW.Chemotherapy and Drug Resistance in Malaria.London: Academic Press, 1987.
4.
ShenJ-XLiGQ. The history of the development of artemisinin derivatives for antimalarial chemotherapy in China. A symposium presentation for the VII International Congress on Infectious Diseases, 12 June 1996, Hong Kong.
5.
HienTTWhiteNJ. Qinghaosu. Lancet1993; 341: 603–8.
6.
WarrellDALooareesuwanSWarrellMJDexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med1982; 306: 313–19.
7.
MolyneuxMETaylorTEWirimaJJBorgsteinA.Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children. QJM1989; 71: 441–59.
8.
MurphySEnglishMWaruiruCAn open randomised trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg1996; 90: 298–301.
9.
van HensbroekBoele MOnyiorahEJaffarSA trial of artemether or quinine in children with cerebral malaria. N Engl J Med1996; 335:69–75.
10.
HienTTDayNPJPhuNHA controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med1996; 335: 76–83.
11.
HienTTArnoldKVinhHComparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg1992; 86: 582–3.
